It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ISRG’s FA Score shows that 1 FA rating(s) are green whileMYO’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ISRG’s TA Score shows that 5 TA indicator(s) are bullish while MYO’s TA Score has 4 bullish TA indicator(s).
ISRG (@Pharmaceuticals: Other) experienced а +2.17% price change this week, while MYO (@Medical/Nursing Services) price change was -46.72% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.98%. For the same industry, the average monthly price growth was -0.45%, and the average quarterly price growth was +12.28%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.82%. For the same industry, the average monthly price growth was +3.72%, and the average quarterly price growth was +3.60%.
ISRG is expected to report earnings on Oct 16, 2025.
MYO is expected to report earnings on Nov 05, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (+2.82% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
ISRG | MYO | ISRG / MYO | |
Capitalization | 172B | 36.9M | 466,125% |
EBITDA | 3.17B | -4.7M | -67,437% |
Gain YTD | -7.989 | -84.860 | 9% |
P/E Ratio | 66.98 | N/A | - |
Revenue | 9.15B | 38.6M | 23,692% |
Total Cash | 5.33B | 21.5M | 24,772% |
Total Debt | 87M | 8.27M | 1,052% |
ISRG | MYO | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 9 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | 29 Undervalued | |
PROFIT vs RISK RATING 1..100 | 32 | 100 | |
SMR RATING 1..100 | 53 | 97 | |
PRICE GROWTH RATING 1..100 | 63 | 98 | |
P/E GROWTH RATING 1..100 | 76 | 100 | |
SEASONALITY SCORE 1..100 | 65 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MYO's Valuation (29) in the Medical Distributors industry is somewhat better than the same rating for ISRG (91) in the Medical Specialties industry. This means that MYO’s stock grew somewhat faster than ISRG’s over the last 12 months.
ISRG's Profit vs Risk Rating (32) in the Medical Specialties industry is significantly better than the same rating for MYO (100) in the Medical Distributors industry. This means that ISRG’s stock grew significantly faster than MYO’s over the last 12 months.
ISRG's SMR Rating (53) in the Medical Specialties industry is somewhat better than the same rating for MYO (97) in the Medical Distributors industry. This means that ISRG’s stock grew somewhat faster than MYO’s over the last 12 months.
ISRG's Price Growth Rating (63) in the Medical Specialties industry is somewhat better than the same rating for MYO (98) in the Medical Distributors industry. This means that ISRG’s stock grew somewhat faster than MYO’s over the last 12 months.
ISRG's P/E Growth Rating (76) in the Medical Specialties industry is in the same range as MYO (100) in the Medical Distributors industry. This means that ISRG’s stock grew similarly to MYO’s over the last 12 months.
ISRG | MYO | |
---|---|---|
RSI ODDS (%) | 4 days ago77% | 4 days ago67% |
Stochastic ODDS (%) | 4 days ago70% | 4 days ago80% |
Momentum ODDS (%) | N/A | 4 days ago87% |
MACD ODDS (%) | 4 days ago61% | 4 days ago88% |
TrendWeek ODDS (%) | 4 days ago69% | 4 days ago87% |
TrendMonth ODDS (%) | 4 days ago62% | 4 days ago88% |
Advances ODDS (%) | 6 days ago72% | 26 days ago78% |
Declines ODDS (%) | 12 days ago58% | 4 days ago88% |
BollingerBands ODDS (%) | 4 days ago89% | 4 days ago85% |
Aroon ODDS (%) | 4 days ago56% | 4 days ago89% |
A.I.dvisor indicates that over the last year, ISRG has been closely correlated with BSX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if ISRG jumps, then BSX could also see price increases.
Ticker / NAME | Correlation To ISRG | 1D Price Change % | ||
---|---|---|---|---|
ISRG | 100% | +0.67% | ||
BSX - ISRG | 73% Closely correlated | -0.94% | ||
SYK - ISRG | 66% Closely correlated | +0.90% | ||
NTRA - ISRG | 54% Loosely correlated | +2.89% | ||
MMSI - ISRG | 52% Loosely correlated | +0.34% | ||
GKOS - ISRG | 49% Loosely correlated | -1.34% | ||
More |
A.I.dvisor tells us that MYO and NTRA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MYO and NTRA's prices will move in lockstep.
Ticker / NAME | Correlation To MYO | 1D Price Change % | ||
---|---|---|---|---|
MYO | 100% | -0.51% | ||
NTRA - MYO | 31% Poorly correlated | +2.89% | ||
RDNT - MYO | 31% Poorly correlated | -1.89% | ||
ISRG - MYO | 31% Poorly correlated | +0.67% | ||
NEO - MYO | 30% Poorly correlated | +0.16% | ||
TWST - MYO | 30% Poorly correlated | -2.50% | ||
More |